Novartis (NVS)
(Delayed Data from NYSE)
$101.11 USD
-0.85 (-0.83%)
Updated May 23, 2024 04:00 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Brokerage Reports
Novartis AG [NVS]
Reports for Purchase
Showing records 421 - 440 ( 475 total )
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Highlights and Key Takeaways from ID Week 2015
Provider: H.C. Wainwright & Co., Inc.
Analyst: BREIDENBACH M
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Oct 3
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Biotechnology/Biopharmaceuticals/BioDefense-Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Sept 12
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker- Week Ended August 29
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 22
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D